Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization

Nirbhai Singh, Elizabeth Macnamara, Saadia Rashid, Jayakrishna Ambati, Christopher D. Kontos, Eric Higgins, Balamurali K. Ambati

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

This study was designed to determine if soluble Tie2 (sTie2) expression inhibits and regresses corneal neovascularization, and if VEGF contributes to its effect. The corneas of BALB/c mice were scraped and the mice were injected with either an adenovirus expressing soluble Tie2 (Ad.sTie2) or an empty adenoviral vector. When injected at the inhibition timepoint (one day prior to corneal injury), the mean percentage of neovascularized corneal area two weeks later in Ad.sTie2-treated mice vs. controls was 56.37 ± 9.15% vs. 85.79 ± 3.55% (p = 0.04). At the regression timepoint (4 weeks after corneal scrape), the mean area of corneal neovascularization in Ad.sTie2-treated mice was 42.89 ± 4.74% vs. 75.01 ± 3.22% in the control group (p = 0.007). VEGF expression was significantly higher in Ad.sTie2-treated mice at the inhibition timepoint and there was no significant difference at the regression timepoint. These findings suggest that sTie2 inhibits and regresses corneal neovascularization in a VEGF-independent manner.

Original languageEnglish (US)
Pages (from-to)194-199
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume332
Issue number1
DOIs
StatePublished - Jun 24 2005
Externally publishedYes

Fingerprint

Corneal Neovascularization
Vascular Endothelial Growth Factor A
Adenoviridae
Cornea
Control Groups

Keywords

  • Angiogenesis
  • Angiopoietin
  • Cornea
  • Inhibition
  • Neovascularization
  • Regression
  • Tie2

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization. / Singh, Nirbhai; Macnamara, Elizabeth; Rashid, Saadia; Ambati, Jayakrishna; Kontos, Christopher D.; Higgins, Eric; Ambati, Balamurali K.

In: Biochemical and Biophysical Research Communications, Vol. 332, No. 1, 24.06.2005, p. 194-199.

Research output: Contribution to journalArticle

Singh, Nirbhai ; Macnamara, Elizabeth ; Rashid, Saadia ; Ambati, Jayakrishna ; Kontos, Christopher D. ; Higgins, Eric ; Ambati, Balamurali K. / Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization. In: Biochemical and Biophysical Research Communications. 2005 ; Vol. 332, No. 1. pp. 194-199.
@article{593a384cc54641e1aa70dd5f3e9b78b7,
title = "Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization",
abstract = "This study was designed to determine if soluble Tie2 (sTie2) expression inhibits and regresses corneal neovascularization, and if VEGF contributes to its effect. The corneas of BALB/c mice were scraped and the mice were injected with either an adenovirus expressing soluble Tie2 (Ad.sTie2) or an empty adenoviral vector. When injected at the inhibition timepoint (one day prior to corneal injury), the mean percentage of neovascularized corneal area two weeks later in Ad.sTie2-treated mice vs. controls was 56.37 ± 9.15{\%} vs. 85.79 ± 3.55{\%} (p = 0.04). At the regression timepoint (4 weeks after corneal scrape), the mean area of corneal neovascularization in Ad.sTie2-treated mice was 42.89 ± 4.74{\%} vs. 75.01 ± 3.22{\%} in the control group (p = 0.007). VEGF expression was significantly higher in Ad.sTie2-treated mice at the inhibition timepoint and there was no significant difference at the regression timepoint. These findings suggest that sTie2 inhibits and regresses corneal neovascularization in a VEGF-independent manner.",
keywords = "Angiogenesis, Angiopoietin, Cornea, Inhibition, Neovascularization, Regression, Tie2",
author = "Nirbhai Singh and Elizabeth Macnamara and Saadia Rashid and Jayakrishna Ambati and Kontos, {Christopher D.} and Eric Higgins and Ambati, {Balamurali K.}",
year = "2005",
month = "6",
day = "24",
doi = "10.1016/j.bbrc.2005.04.108",
language = "English (US)",
volume = "332",
pages = "194--199",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization

AU - Singh, Nirbhai

AU - Macnamara, Elizabeth

AU - Rashid, Saadia

AU - Ambati, Jayakrishna

AU - Kontos, Christopher D.

AU - Higgins, Eric

AU - Ambati, Balamurali K.

PY - 2005/6/24

Y1 - 2005/6/24

N2 - This study was designed to determine if soluble Tie2 (sTie2) expression inhibits and regresses corneal neovascularization, and if VEGF contributes to its effect. The corneas of BALB/c mice were scraped and the mice were injected with either an adenovirus expressing soluble Tie2 (Ad.sTie2) or an empty adenoviral vector. When injected at the inhibition timepoint (one day prior to corneal injury), the mean percentage of neovascularized corneal area two weeks later in Ad.sTie2-treated mice vs. controls was 56.37 ± 9.15% vs. 85.79 ± 3.55% (p = 0.04). At the regression timepoint (4 weeks after corneal scrape), the mean area of corneal neovascularization in Ad.sTie2-treated mice was 42.89 ± 4.74% vs. 75.01 ± 3.22% in the control group (p = 0.007). VEGF expression was significantly higher in Ad.sTie2-treated mice at the inhibition timepoint and there was no significant difference at the regression timepoint. These findings suggest that sTie2 inhibits and regresses corneal neovascularization in a VEGF-independent manner.

AB - This study was designed to determine if soluble Tie2 (sTie2) expression inhibits and regresses corneal neovascularization, and if VEGF contributes to its effect. The corneas of BALB/c mice were scraped and the mice were injected with either an adenovirus expressing soluble Tie2 (Ad.sTie2) or an empty adenoviral vector. When injected at the inhibition timepoint (one day prior to corneal injury), the mean percentage of neovascularized corneal area two weeks later in Ad.sTie2-treated mice vs. controls was 56.37 ± 9.15% vs. 85.79 ± 3.55% (p = 0.04). At the regression timepoint (4 weeks after corneal scrape), the mean area of corneal neovascularization in Ad.sTie2-treated mice was 42.89 ± 4.74% vs. 75.01 ± 3.22% in the control group (p = 0.007). VEGF expression was significantly higher in Ad.sTie2-treated mice at the inhibition timepoint and there was no significant difference at the regression timepoint. These findings suggest that sTie2 inhibits and regresses corneal neovascularization in a VEGF-independent manner.

KW - Angiogenesis

KW - Angiopoietin

KW - Cornea

KW - Inhibition

KW - Neovascularization

KW - Regression

KW - Tie2

UR - http://www.scopus.com/inward/record.url?scp=19344365737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19344365737&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2005.04.108

DO - 10.1016/j.bbrc.2005.04.108

M3 - Article

C2 - 15896317

AN - SCOPUS:19344365737

VL - 332

SP - 194

EP - 199

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -